Cellectis

YTD

ALL

Why Robinhood?

You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!

About CLLS

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J.

CEO

André Choulika

CEOAndré Choulika

Employees

222

Employees222

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

2000

Founded2000

Employees

222

Employees222

CLLS Key Statistics

Market cap

252.50M

Market cap252.50M

Price-Earnings ratio

-6.05

Price-Earnings ratio-6.05

Dividend yield

—

Dividend yield—

Average volume

56.66K

Average volume56.66K

High today

$3.63

High today$3.63

Low today

$3.36

Low today$3.36

Open price

$3.46

Open price$3.46

Volume

14.41K

Volume14.41K

52 Week high

$5.48

52 Week high$5.48

52 Week low

$1.10

52 Week low$1.10

CLLS News

TipRanks 1d

Cellectis to Announce Q3 2025 Financial Results on November 7

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell